A group of researchers harnessing the power of light to control gene expression has dramatically improved its method, optimizing speed and precision, and opening new research avenues for scientists who employ optogenetics — the use of light and genetic engineering to control cells.
Immunology Professor Jennifer Manilay and bioengineering Professor Joel Spencer are using a new grant from the National Institutes of Health (NIH) to expand a project they’ve been working on for the past two years — delving into the immune systems of living mice to see how B-cells develop under different circumstances.
A new community health project addressing asthma issues in the San Joaquin Valley is underway thanks to a collaboration between UC Merced, UCSF and Camarena Health, supported by a grant from biotechnology giant Genentech.
A new community health project addressing asthma issues in the San Joaquin Valley is underway thanks to a collaboration between UC Merced, UCSF and Camarena Health, supported by a grant from biotechnology giant Genentech’s foundation.
Two new projects designed and led by UC Merced researchers will address challenges facing many Californians — wildfire recovery and agricultural labor — but will also have global reach.
Professor Michael Thompson doesn’t usually work in immunology or drug development. But his use of X-ray crystallography — research that visualizes the structures of protein molecules to better understand how they function — has taken him in a new direction.
About 35 percent of Americans have metabolic syndrome, a group of risk factors that raises the risk of cardiovascular disease — the leading cause of death in the United States.
If you have three of these five issues, you have metabolic syndrome, according to the American Heart Association:
About 70 percent of people with COVID-19 suddenly lose their sense of smell, although fewer of them seem to realize it, according to a new “living analysis” by a research team that includes a UC Merced graduate student.
Biophysical chemistry Professor Shahar Sukenik and the graduate students in his lab are trying to make sense out of what might seem to some to be chaos. They aim to better understand how a series of floppy, malleable proteins function — or malfunction — inside cells.
The work has earned Sukenik a $1.86 million, five-year Outstanding Investigator award from the National Institutes for Health (NIH).